13F-HR filed by UBS Group AG
UBS Group AG filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 10,515 holding rows worth $299,954,215,000.
- Accession
- 0000950123-22-005967
- Filer
- CIK 1610520
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A combination report, 19,884 entries on the cover page, a total value of $299,954,215,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $299,954,215,000 with VALUE read as thousands by filing date, 13F file number 028-16612. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerUBS ASSET MANAGEMENT (AMERICAS) INC 028-02682
- reports for this filerUBS OCONNOR LLC 028-06327
- included managerUBS Financial Services Inc 028-11496
- included managerUBS Swiss Financial Advisors AG 028-11603
- included managerUBS AG 028-10396
- included managerUBS Switzerland AG 028-21410
- included managerUBS Securities Japan Co., Ltd 028-21660
- included managerUBS Europe SE 028-21431
- included managerUBS Bank (Canada) 028-22388
- included managerUBS La Maison de Gestion 028-21440
- included managerUBS Securities LLC 028-21412
- included managerUBS Gestion SGIIC, SA 028-21441
- included managerUBS Brasil Administradora de Valores Mobiliarios Ltda 028-21429
- included managerUBS (Monaco) SA
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MANA CAP ACQUISITION CORP | 56168P112 | RIGHT 06/01/2024 | 803 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| SANABY HEALTH ACQUISITION CO | 79956P201 | UNIT 07/30/2028 | 39 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| VTAQW 30SEP25 11.5 C | 92280L119 | COM | 49 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| WTS/ACKRELL SPAC PARTNERS I CO. EXP12/01/2026 | 00461L113 | COM | 504 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| SPRINGBIG HOLDIN | G9118J119 | EQUITY WRT | 958 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| CLEANTECH ACQUISITION CORP | 18453L123 | RIGHT 10/15/2026 | 1,176 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| KIORA PHARMACEUTICALS INC | 49721T101 | COMMON STOCK | 333 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| GOLDEN PATH ACQUISITION CORP | G4028H113 | RIGHT 01/31/2028 | 4 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| RBB FD INC | 74933W734 | DRIVEWEALTH STE | 13 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| GLOBAL BETA ETF TR | 37959X209 | LOW BETA ETF | 7 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| CITIUS PHARMACEUTICALS INC | 17322U116 | *W EXP 08/08/202 | 203 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| QUHUO LTD | 74841Q100 | ADS | 292 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| MALLARD ACQUISITION CORP | 561204116 | *W EXP 06/30/202 | 5,672 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| SIMPLIFY EXCHANGE TRADED FUN | 82889N806 | VOLT POP CULTURE | 54 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
| ENDRA LIFE SCIENCES INC | 29273B112 | *W EXP 05/08/202 | 16,834 | $0 | thousands by filing date | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-005967 | this filing | 2022-05-16 | acceptance time not in the bulk data set |